Comparison of Efficacy of Pembrolizumab Between Epstein-Barr Virus‒Positive and ‒Negative Relapsed or Refractory Non-Hodgkin Lymphomas
Cancer Research and Treatment - South Korea
doi 10.4143/crt.2018.191
Full Text
Open PDFAbstract
Available in full text
Date
April 15, 2019
Authors
Publisher
Korean Cancer Association